These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37097843)

  • 1. Barriers and Facilitators to the Equitable Access of Psychedelic Medical Care and Research in Alzheimer's Disease and Related Dementias.
    Rudolph KA
    AJOB Neurosci; 2023; 14(2):136-138. PubMed ID: 37097843
    [No Abstract]   [Full Text] [Related]  

  • 2. Journeying to Ixtlan: Ethics of Psychedelic Medicine and Research for Alzheimer's Disease and Related Dementias.
    Peterson A; Largent EA; Lynch HF; Karlawish J; Sisti D
    AJOB Neurosci; 2023; 14(2):107-123. PubMed ID: 36476106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease and other dementias: advances in 2014.
    Bateman R
    Lancet Neurol; 2015 Jan; 14(1):4-6. PubMed ID: 25496880
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychedelic Research for Dementia Risks Perpetuating Structural Failures and Inadequacies in Aged Care.
    Soofi H; Forlini C
    AJOB Neurosci; 2023; 14(2):131-134. PubMed ID: 37097855
    [No Abstract]   [Full Text] [Related]  

  • 5. Avoiding the Premature Introduction of Psychedelic Medicines in Alzheimer's Disease and Related Disorders.
    Carter A; Graham M; Hall W; Barber M; Gardner J
    AJOB Neurosci; 2023; 14(2):129-131. PubMed ID: 37097862
    [No Abstract]   [Full Text] [Related]  

  • 6. Implications from Jaworska's Account of Autonomy and Self for Dementia and Psychedelic Research.
    Kopeikin ZA
    AJOB Neurosci; 2023; 14(2):142-144. PubMed ID: 37097873
    [No Abstract]   [Full Text] [Related]  

  • 7. Imagining a Role for Psychedelics in Dementia Care.
    George DR; Hanson R
    Am J Geriatr Psychiatry; 2019 Sep; 27(9):1028-1030. PubMed ID: 31047789
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs for Alzheimer's disease and related dementias.
    Gauthier S
    BMJ; 2005 Apr; 330(7496):857-8. PubMed ID: 15831849
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 10. Risperidone in the treatment of elderly patients with psychosis of Alzheimer's disease and related dementias.
    Grossman F; Okamoto A; Turkoz I; Gharabawi G
    J Am Geriatr Soc; 2004 May; 52(5):852-3. PubMed ID: 15086685
    [No Abstract]   [Full Text] [Related]  

  • 11. 2021 Alzheimer's disease facts and figures.
    Alzheimers Dement; 2021 Mar; 17(3):327-406. PubMed ID: 33756057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitators, Challenges, and Messaging Strategies for Hispanic/Latino Populations Participating in Alzheimer's Disease and Related Dementias Clinical Research: A Literature Review.
    Massett HA; Mitchell AK; Alley L; Simoneau E; Burke P; Han SH; Gallop-Goodman G; McGowan M
    J Alzheimers Dis; 2021; 82(1):107-127. PubMed ID: 33998537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drugs for Alzheimer's disease and other dementias.
    Bullock R
    Br J Psychiatry; 2002 Feb; 180():135-9. PubMed ID: 11823323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive pharmacotherapy of Alzheimer's disease and other dementias.
    Herrmann N
    Can J Psychiatry; 2002 Oct; 47(8):715-22. PubMed ID: 12420649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease and other dementias: update on research.
    Schneider L
    Lancet Neurol; 2017 Jan; 16(1):4-5. PubMed ID: 27979354
    [No Abstract]   [Full Text] [Related]  

  • 16. An Overview of Primary Dementias as Clinicopathological Entities.
    Salardini A
    Semin Neurol; 2019 Apr; 39(2):153-166. PubMed ID: 30925609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms.
    Garcia-Romeu A; Darcy S; Jackson H; White T; Rosenberg P
    Curr Top Behav Neurosci; 2022; 56():287-317. PubMed ID: 34734390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CRH in the pathogenesis of dementia of Alzheimer's type and other dementias.
    Rehman HU
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1637-42. PubMed ID: 12476966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Declining prevalence of dementia in the U.S. elderly population.
    Manton KC; Gu XL; Ukraintseva SV
    Adv Gerontol; 2005; 16():30-7. PubMed ID: 16075674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias.
    Ihl R; Frölich L; Winblad B; Schneider L; Burns A; Möller HJ;
    World J Biol Psychiatry; 2011 Feb; 12(1):2-32. PubMed ID: 21288069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.